Treating bone disease in multiple myeloma
Dr Evangelos Terpos - University of Athens, Greece
Treating bone disease in multiple myeloma ( Dr Evangelos Terpos - University of Athens, Greece )
16 Jul 2010
Next generation proteasome inhibitors
Dr Keith Stewart - Mayo Clinic, Arizona, USA
Next generation proteasome inhibitors ( Dr Keith Stewart - Mayo Clinic, Arizona, USA )
16 Jul 2010
Views on the joint ASCO-ASH education session
Dr Elisabeth Pitterman - Hanusch Hospital, Vienna, Austria
Views on the joint ASCO-ASH education session ( Dr Elisabeth Pitterman - Hanusch Hospital, Vienna, Austria )
15 Jul 2010
Views on the joint ASCO-ASH education session
Dr Elisabeth Pitterman - Hanusch Hospital, Vienna, Austria
Views on the joint ASCO-ASH education session ( Dr Elisabeth Pitterman - Hanusch Hospital, Vienna, Austria )
15 Jul 2010
Frontline treatments for lymphomas
Professor Bruce Cheson, Lombardi Comprehensive Cancer Center, Washington DC, USA
Frontline treatments for lymphomas ( Professor Bruce Cheson, Lombardi Comprehensive Cancer Center, Washington DC, USA )
6 Jul 2010
EHA 2010: Experts discuss treatment of elderly cancer patients
Prof Gordon McVie, Prof Richard Sullivan, Prof Reinhard Stauder, Prof Mario Bocc...
EHA 2010: Experts discuss treatment of elderly cancer patients ( Prof Gordon McVie, Prof Richard Sullivan, Prof Reinhard Stauder, Prof Mario Boccadoro, Prof Pierre Fenaux )
30 Jun 2010
Results of the multiple myeloma study comparing zoledronic acid to clodronate
Prof Gareth Morgan - Institute of Cancer Research, Sutton, UK
Results of the multiple myeloma study comparing zoledronic acid to clodronate ( Prof Gareth Morgan - Institute of Cancer Research, Sutton, UK )
25 Jun 2010
The efficacy of bendamustine and rituximab in the treatment of indolent lymphoma...
Dr Mathias Rummel - University Hospital, Giessen, Germany
The efficacy of bendamustine and rituximab in the treatment of indolent lymphoma diseases ( Dr Mathias Rummel - University Hospital, Giessen, Germany )
25 Jun 2010
Progress in myeloma survival rates
Professor Jesús San-Miguel - University Hospital of Salamanca, Spain
Progress in myeloma survival rates ( Professor Jesús San-Miguel - University Hospital of Salamanca, Spain )
25 Jun 2010
Personalised and reduced therapy for Hodgkin's lymphoma
Prof Volker Diehl - University of Cologne, Germany
Personalised and reduced therapy for Hodgkin's lymphoma ( Prof Volker Diehl - University of Cologne, Germany )
16 Apr 2010
Roundtable discussion on the latest advances in multiple myeloma therapy
Prof Gordon McVie, Prof Thierry Facon, Prof Meletios Dimopoulos, Prof Heinz Ludw...
Roundtable discussion on the latest advances in multiple myeloma therapy ( Prof Gordon McVie, Prof Thierry Facon, Prof Meletios Dimopoulos, Prof Heinz Ludwig )
2 Mar 2010
ASH 2009: Bortezomib, lenalidomide, liposomal doxorubicin and dexamethasone for ...
Prof Andrzej Jakubowiak - University of Michigan Comprehensive Cancer Center, US...
ASH 2009: Bortezomib, lenalidomide, liposomal doxorubicin and dexamethasone for multiple myeloma ( Prof Andrzej Jakubowiak - University of Michigan Comprehensive Cancer Center, USA )
1 Mar 2010